Skip to main content
Clinical Trials/NCT07545148
NCT07545148
Not yet recruiting
Not Applicable

REVEAL-OAB. Real-world Experiences and Voices Exploring the Actual Lived Burden of OAB: A Mixed-methods Multi-country PROMs Study on OAB Patients' Quality of Life

European Association of Urology Research Foundation0 sites2,000 target enrollmentStarted: July 1, 2026Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
European Association of Urology Research Foundation
Enrollment
2,000
Primary Endpoint
Sexual matters

Overview

Brief Summary

The main goal is to understand what it is truly like to live with OAB from the patient's perspective, including how it affects: daily activities, emotional wellbeing and mental health, social life and relationships, work and overall quality of life.

Detailed Description

The REVEAL-OAB (Real-world Experiences and Voices Exploring the Actual Lived burden of Overactive Bladder) study is a large, international, mixed-methods research program designed to capture both the measurable burden and the lived experience of overactive bladder (OAB).Quantitatively, it uses structured surveys and validated patient-reported outcome measures to assess symptom severity (e.g., urgency, frequency, incontinence), health-related quality of life, healthcare utilization, and treatment patterns across diverse populations. Qualitatively, it incorporates in-depth patient interviews, open-ended survey responses, and narrative data to explore how OAB affects emotional wellbeing, social functioning, relationships, and daily decision-making. By integrating these quantitative metrics with rich qualitative insights, the study aims to provide a comprehensive, patient-centered understanding of OAB, identify unmet needs in care, and inform more effective clinical management and health policy.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • If they are over 18 years old.
  • They have been told by a doctor or other healthcare professional that they have symptoms that match OAB, or have been given a diagnosis of OAB.
  • They live in France, Germany, Italy, the Netherlands, Poland, Spain, Sweden, or the UK.
  • They have received the Patient Information Sheet from their health care provider, during an appointment, via email, or postal mail.
  • They can confirm they understand the Patient Information Sheet and that they want to take part in this study.

Exclusion Criteria

  • They have not received information on this study from their own health care provider
  • They have a confirmed neurological condition known to affect bladder function (for example: multiple sclerosis, Parkinson's disease, spinal cord injury).
  • They have undergone major surgery directly involving the bladder, prostate, urethra, or pelvic structures that affect urinary function.
  • They presently have a urinary tract infection (UTI).
  • They have or have had cancer in their bladder, kidneys, prostate, or other urinary or reproductive organs

Outcomes

Primary Outcomes

Sexual matters

Time Frame: Past four weeks

Participants achieved a response if they scored a bother status of 0 or 1 on a scale ranging from 0 (not at all) to 10 (a lot)

OAB symptom severity and frequency

Time Frame: Pats four weeks

Participants achieved a response if they scored a bother status of 0 or 1 on a scale ranging from 0 (not at all) to 10 (a great deal)

Quality of Life relating to bladder symptoms

Time Frame: Past four weeks

1 is equivalent to 'none of the time' and 6 is equivalent to 'all of the time'

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
European Association of Urology Research Foundation
Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials